BioCentury | Oct 20, 2016
Translation in Brief

Killer burn

...thinks α-GalCer could be an anti-obesity therapy. The sea sponge-derived sphingolipid was originally identified by Kirin Brewery...
...maximal weight loss in GLP1 therapy.” Cell Metabolism (2016) -Karen Tkach Karen Tkach Beth Israel Deaconess Harvard Medical School Kirin Brewery Co. Ltd. Regimmune...
BioCentury | Jun 17, 2013
Strategy

Grounded in Japan

...the programs to Takeda (see BioCentury, Feb. 11, 2008) . The biotech's 1984 JV with Kirin Brewery Co. Ltd....
BioCentury | Oct 22, 2012
Strategy

NPS's niche save

...discovery effort was cinacalcet, an oral calcimimetic that was out-licensed to the pharmaceutical division of Kirin Brewery Co. Ltd....
...BCIQ: BioCentury Online Intelligence A. 5/26/94 - Raises $11M in IPO.B. June 1995 - Grants Kirin Brewery Co. Ltd....
BioCentury | Oct 31, 2011
Clinical News

KRN5500: Additional Phase IIa data

...U.S to treat chemotherapy-induced neuropathic pain in cancer patients. Dara BioSciences Inc. (NASDAQ:DARA), Raleigh, N.C. Kirin Brewery Co. Ltd....
BioCentury | Oct 3, 2011
Finance

Value verification

...dysfunction (ED) Submit regulatory application in Latin America 4Q11 Aveo Pharmaceuticals Inc. (NASDAQ:AVEO)/Astellas Pharma Inc. (Tokyo:4503)/Kirin Brewery Co. Ltd....
BioCentury | Sep 19, 2011
Company News

Massachusetts General Hospital Cancer Center cancer, pharmacogenetics news

...RCC). Aveo has rights to the inhibitor of VEGF receptors 1, 2 and 3 from Kirin Brewery Co. Ltd....
BioCentury | Aug 22, 2011
Clinical News

KRN5500 regulatory update

...the indication. Dara has rights to KRN5500 from Kirin. Dara BioSciences Inc. (NASDAQ:DARA), Raleigh, N.C. Kirin Brewery Co. Ltd....
BioCentury | Jul 4, 2011
Finance

3Q Financial Markets Preview: Flavored with Phase III

...diabetes FDA panel; PDUFA date 7/19/11; 10/28/11 Aveo Pharmaceuticals Inc. (NASDAQ:AVEO)/ Astellas Pharma Inc. (Tokyo:4503)/ Kirin Brewery Co. Ltd....
BioCentury | May 2, 2011
Clinical News

Tivozanib: Phase III ongoing

...Calif.) market Nexavar. Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Kirin Brewery Co. Ltd....
BioCentury | Apr 4, 2011
Finance

ASCO and Beyond

...MAA 2Q11 Isotechnika Pharma Inc. (TSX:ISA)/Lux Biosciences Inc. Voclera voclosporin Non-infectious uveitis MAA action 2Q11 Kirin Brewery Co. Ltd....
Items per page:
1 - 10 of 206
BioCentury | Oct 20, 2016
Translation in Brief

Killer burn

...thinks α-GalCer could be an anti-obesity therapy. The sea sponge-derived sphingolipid was originally identified by Kirin Brewery...
...maximal weight loss in GLP1 therapy.” Cell Metabolism (2016) -Karen Tkach Karen Tkach Beth Israel Deaconess Harvard Medical School Kirin Brewery Co. Ltd. Regimmune...
BioCentury | Jun 17, 2013
Strategy

Grounded in Japan

...the programs to Takeda (see BioCentury, Feb. 11, 2008) . The biotech's 1984 JV with Kirin Brewery Co. Ltd....
BioCentury | Oct 22, 2012
Strategy

NPS's niche save

...discovery effort was cinacalcet, an oral calcimimetic that was out-licensed to the pharmaceutical division of Kirin Brewery Co. Ltd....
...BCIQ: BioCentury Online Intelligence A. 5/26/94 - Raises $11M in IPO.B. June 1995 - Grants Kirin Brewery Co. Ltd....
BioCentury | Oct 31, 2011
Clinical News

KRN5500: Additional Phase IIa data

...U.S to treat chemotherapy-induced neuropathic pain in cancer patients. Dara BioSciences Inc. (NASDAQ:DARA), Raleigh, N.C. Kirin Brewery Co. Ltd....
BioCentury | Oct 3, 2011
Finance

Value verification

...dysfunction (ED) Submit regulatory application in Latin America 4Q11 Aveo Pharmaceuticals Inc. (NASDAQ:AVEO)/Astellas Pharma Inc. (Tokyo:4503)/Kirin Brewery Co. Ltd....
BioCentury | Sep 19, 2011
Company News

Massachusetts General Hospital Cancer Center cancer, pharmacogenetics news

...RCC). Aveo has rights to the inhibitor of VEGF receptors 1, 2 and 3 from Kirin Brewery Co. Ltd....
BioCentury | Aug 22, 2011
Clinical News

KRN5500 regulatory update

...the indication. Dara has rights to KRN5500 from Kirin. Dara BioSciences Inc. (NASDAQ:DARA), Raleigh, N.C. Kirin Brewery Co. Ltd....
BioCentury | Jul 4, 2011
Finance

3Q Financial Markets Preview: Flavored with Phase III

...diabetes FDA panel; PDUFA date 7/19/11; 10/28/11 Aveo Pharmaceuticals Inc. (NASDAQ:AVEO)/ Astellas Pharma Inc. (Tokyo:4503)/ Kirin Brewery Co. Ltd....
BioCentury | May 2, 2011
Clinical News

Tivozanib: Phase III ongoing

...Calif.) market Nexavar. Aveo Pharmaceuticals Inc. (NASDAQ:AVEO), Cambridge, Mass. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Kirin Brewery Co. Ltd....
BioCentury | Apr 4, 2011
Finance

ASCO and Beyond

...MAA 2Q11 Isotechnika Pharma Inc. (TSX:ISA)/Lux Biosciences Inc. Voclera voclosporin Non-infectious uveitis MAA action 2Q11 Kirin Brewery Co. Ltd....
Items per page:
1 - 10 of 206